ATE524180T1 - Mittel zur prophylaxe oder behandlung von alkoholabhängigkeit oder drogenabhängigkeit - Google Patents

Mittel zur prophylaxe oder behandlung von alkoholabhängigkeit oder drogenabhängigkeit

Info

Publication number: ATE524180T1
Authority: AT; Austria
Prior art keywords: prophylaxis; treatment; agents; drug addiction; alcohol dependence
Prior art date: 2006-10-16

Application number

AT07830236T

Other languages

English (en)

Inventor

Koji Teshima

Roberto Ciccocioppo

Maurizio Massi

Original Assignee

Mitsubishi Tanabe Pharma Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-16

Filing date

2007-10-16

Publication date

2011-09-15

2007-10-16 Application filed by Mitsubishi Tanabe Pharma Corp filed Critical Mitsubishi Tanabe Pharma Corp

2011-09-15 Application granted granted Critical

2011-09-15 Publication of ATE524180T1 publication Critical patent/ATE524180T1/de

Links

208000011117 substance-related disease Diseases 0.000 title abstract 3
238000011321 prophylaxis Methods 0.000 title abstract 2
238000011282 treatment Methods 0.000 title abstract 2
208000007848 Alcoholism Diseases 0.000 title 1
201000007930 alcohol dependence Diseases 0.000 title 1
239000003795 chemical substances by application Substances 0.000 title 1
206010013663 drug dependence Diseases 0.000 title 1
PJANMOWVUZBDQF-XMMPIXPASA-N 2-[3-[1-[(1r)-1,2-dihydroacenaphthylen-1-yl]piperidin-4-yl]-2-oxobenzimidazol-1-yl]-n-methylacetamide Chemical compound C1=CC([C@H](N2CCC(CC2)N2C3=CC=CC=C3N(C2=O)CC(=O)NC)C2)=C3C2=CC=CC3=C1 PJANMOWVUZBDQF-XMMPIXPASA-N 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
201000009032 substance abuse Diseases 0.000 abstract 1
231100000736 substance abuse Toxicity 0.000 abstract 1
201000006152 substance dependence Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Addiction (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Neurology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT07830236T 2006-10-16 2007-10-16 Mittel zur prophylaxe oder behandlung von alkoholabhängigkeit oder drogenabhängigkeit ATE524180T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP06122336		2006-10-16
PCT/JP2007/070502 WO2008050698A2 (en)	2006-10-16	2007-10-16	Agent for prophylaxis or treatment of alcohol dependence or drug dependence

Publications (1)

Publication Number	Publication Date
ATE524180T1 true ATE524180T1 (de)	2011-09-15

Family

ID=37806857

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT07830236T ATE524180T1 (de)	2006-10-16	2007-10-16	Mittel zur prophylaxe oder behandlung von alkoholabhängigkeit oder drogenabhängigkeit

Country Status (16)

Country	Link
US (1)	US8207201B2 (de)
EP (1)	EP2089030B1 (de)
JP (1)	JP5089687B2 (de)
KR (1)	KR101187509B1 (de)
CN (1)	CN101600433B (de)
AT (1)	ATE524180T1 (de)
AU (1)	AU2007310209B2 (de)
BR (1)	BRPI0717161A2 (de)
CA (1)	CA2666630C (de)
DK (1)	DK2089030T3 (de)
ES (1)	ES2370276T3 (de)
MX (1)	MX2009004012A (de)
PL (1)	PL2089030T3 (de)
PT (1)	PT2089030E (de)
RU (1)	RU2419433C2 (de)
WO (1)	WO2008050698A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW201016675A (en) *	2008-09-16	2010-05-01	Mitsubishi Tanabe Pharma Corp	Crystalline benzoimidazole compound and salt thereof
TWI582096B (zh) *	2011-12-06	2017-05-11	美國禮來大藥廠	用於酒精依賴及濫用處理之４',５'－二氫螺［哌啶－４,７'－噻吩并[２，３－c]哌喃］化合物
CA3224323A1 (en) *	2021-07-14	2023-01-19	Jian Wang	Piperidine derivative, and pharmaceutical composition thereof, preparation method therefor, and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL342046A1 (en)	1998-01-19	2001-05-21	Pfizer	4-(2-keto-1-benzimidazolinyl)piperidine compounds as agonists of orl1 receptor
US7566728B2 (en)	2002-03-29	2009-07-28	Mitsubishi Tanabe Pharma Corporation	Remedy for sleep disturbance
SA04250305B1 (ar)	2003-09-25	2008-06-02	سولفاي فارماسوتيكالز بي . في	مشتقات بنزيميدازولون cenzimidazolone وكينازولينون quinazolinone كمساعادات على مستقبلات ORL1 البشرية
WO2006025267A1 (ja) *	2004-08-31	2006-03-09	Mitsubishi Pharma Corporation	Per2タンパク質レベルの低下を作用機序とする睡眠障害治療薬
TW201016675A (en) *	2008-09-16	2010-05-01	Mitsubishi Tanabe Pharma Corp	Crystalline benzoimidazole compound and salt thereof

2007
- 2007-10-16 CA CA2666630A patent/CA2666630C/en not_active Expired - Fee Related
- 2007-10-16 AU AU2007310209A patent/AU2007310209B2/en not_active Ceased
- 2007-10-16 JP JP2009515664A patent/JP5089687B2/ja not_active Expired - Fee Related
- 2007-10-16 CN CN2007800386397A patent/CN101600433B/zh not_active Expired - Fee Related
- 2007-10-16 US US12/311,861 patent/US8207201B2/en not_active Expired - Fee Related
- 2007-10-16 RU RU2009118439/15A patent/RU2419433C2/ru not_active IP Right Cessation
- 2007-10-16 EP EP07830236A patent/EP2089030B1/de not_active Not-in-force
- 2007-10-16 PL PL07830236T patent/PL2089030T3/pl unknown
- 2007-10-16 PT PT07830236T patent/PT2089030E/pt unknown
- 2007-10-16 KR KR1020097010031A patent/KR101187509B1/ko not_active Expired - Fee Related
- 2007-10-16 AT AT07830236T patent/ATE524180T1/de active
- 2007-10-16 DK DK07830236.1T patent/DK2089030T3/da active
- 2007-10-16 MX MX2009004012A patent/MX2009004012A/es active IP Right Grant
- 2007-10-16 WO PCT/JP2007/070502 patent/WO2008050698A2/en not_active Ceased
- 2007-10-16 ES ES07830236T patent/ES2370276T3/es active Active
- 2007-10-16 BR BRPI0717161-7A patent/BRPI0717161A2/pt not_active IP Right Cessation

Also Published As

Publication number	Publication date
KR101187509B1 (ko)	2012-10-02
CA2666630A1 (en)	2008-05-02
DK2089030T3 (da)	2011-12-05
ES2370276T3 (es)	2011-12-14
KR20090069336A (ko)	2009-06-30
PL2089030T3 (pl)	2012-02-29
EP2089030B1 (de)	2011-09-14
RU2419433C2 (ru)	2011-05-27
WO2008050698A3 (en)	2008-10-02
PT2089030E (pt)	2011-09-27
JP5089687B2 (ja)	2012-12-05
RU2009118439A (ru)	2010-11-27
BRPI0717161A2 (pt)	2013-10-15
CN101600433B (zh)	2012-09-26
CN101600433A (zh)	2009-12-09
EP2089030A2 (de)	2009-08-19
AU2007310209B2 (en)	2011-11-17
US8207201B2 (en)	2012-06-26
JP2010505746A (ja)	2010-02-25
AU2007310209A1 (en)	2008-05-02
WO2008050698A2 (en)	2008-05-02
MX2009004012A (es)	2009-04-27
US20100069382A1 (en)	2010-03-18
CA2666630C (en)	2012-01-24

Similar Documents

Publication	Publication Date	Title
TW200615266A (en)	2006-05-16	Organic compounds
NO20090628L (no)	2009-04-21	Pyridizinon derivativater
NO20070557L (no)	2007-01-30	Ftalazinderivater som PARP-inhibitorer
EA200970447A1 (ru)	2009-10-30	Соединения и композиции в качестве ингибиторов протеинкиназы
EA200900613A1 (ru)	2009-10-30	Спирокетоновые ингибиторы ацетил-коа-карбоксилаз
DE602006017694D1 (de)	2010-12-02	C-verknüpfte zyklische antagonisten des p2y1-rezeptors mit eignung bei der behandlung thrombotischer leiden
EA200970595A1 (ru)	2010-02-26	Производные замещенных индазолов, активные в качестве ингибиторов киназ
ATE430747T1 (de)	2009-05-15	2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren
EP2607348A3 (de)	2013-10-16	Hemmer des plasminogen-aktivator-inhibitors 1
MX2009011276A (es)	2010-01-15	Inhibidor de dpp-iv que incluye el grupo beta-amino, metodo para la preparacion del mismo y composicion farmaceutica que contiene el mismo para prevenir y tratar una diabetes o una obesidad.
EA201170680A1 (ru)	2011-12-30	Ингибиторы акт и p70 s6-киназы
EA200970532A1 (ru)	2009-10-30	Фумаратная соль (альфа s, бета r)-6-бром-альфа-[2-(диметиламино)этил]-2-метокси-альфа-1-нафталенил-бета-фенил-3-хинолинэтанола
DK2054418T3 (da)	2012-02-27	Dihydrothieno-pyrimidiner som AKT-proteinkinase-inhibitorer
MY148375A (en)	2013-04-15	Delta and epsilon crystal forms of imatinib mesylate
EA201270590A1 (ru)	2012-09-28	Ингибиторы акт
IL205697A0 (en)	2010-11-30	4(-3-(-2-(phenyl)morpholino)-2-oxopyrrolidin-1-yl)-n-(thiazole-2-yl)benzenesulfon-amide derivatives, compositions comprising the same and uses thereof
NO20071314L (no)	2007-05-10	Peptidiske vasopressinreseptoragonister
WO2006087543A8 (en)	2007-10-18	Antibacterial piperidine derivatives
PH12019500394A1 (en)	2020-01-20	Bicyclic nitrogenated heterocyclic compound
DE602004008959D1 (de)	2007-10-25	Benzoäbüä1,4üdioxepinderivate
EA201071395A1 (ru)	2011-06-30	Ингибитор толерантности к анальгетику
MX2007004248A (es)	2007-06-12	Derivados heterociclicos de bisarilurea sustituidos como inhibidores de cinasa.
DE602006020871D1 (de)	2011-05-05	Lineare harnstoffmimetika-antagonisten des p2y1-rezeptors zur behandlung von thromboseleiden
ATE384529T1 (de)	2008-02-15	Synergistische kombination enthaltend roflumilast und einen anticholinergischen wirkstoff ausgewählt aus tiotropiumsalzen für die behandlung von atemwegserkrankungen
UA97348C2 (en)	2012-02-10	HETEROCYCLIC NF-kB INHIBITORS

Legal Events

Date

Code

Title

Description

2012-03-15

UEP

Publication of translation of european patent specification

Ref document number: 2089030

Country of ref document: EP